CARDIOMYOPLASTY REVIEW - PHYSIOLOGICAL PRINCIPLES AND CHARACTERISTICSOF ELECTRICALLY STIMULATED SKELETAL-MUSCLE .2. A THERAPEUTIC OPTION

Chronic heart failure continues unsolved as ever despite recent advanc es in cardiac surgery and pharmacological new armamentarium and remain s a significant cause of death, regardless of etiology. Cardiomyoplast y (CMP), a new form of biomechanical ventricular support, has given ne w life to the field of mechanical circulatory support, providing a ''b ridge'' to transplantation and serving as a possible alternative to su rgical treatment. The geographic distribution of world experience in 4 01 patients showns that 80% were centralized in Europe (50%) and South America (30%). This review of the data analysis, documented improved changes in patients clinical status, further clarifies and appropriate patient population indications for DCMP as web as that more than 80% survival probability for NYHA class II and III and an early procedure related mortality of 8 to 10%.